Published online
doi:10.1084/jem.20070657
The Journal of Experimental Medicine, Vol. 204, No. 10, 2449-2460
The Rockefeller University Press, 0022-1007 $30.00
© Guzik et al.
Role of the T cell in the genesis of angiotensin II–induced hypertension and vascular dysfunction
Tomasz J. Guzik1,2,
Nyssa E. Hoch1,2,
Kathryn A. Brown1,2,
Louise A. McCann1,2,
Ayaz Rahman1,2,
Sergey Dikalov1,2,
Jorg Goronzy1,2,
Cornelia Weyand1,2, and
David G. Harrison1,2,3
1 Division of Cardiology and 2 Lowance Center for Human Immunology, Department of Medicine, Emory University School of Medicine, Atlanta, GA 30033
3 Atlanta Veteran Administration Hospital, Atlanta, GA 30033
CORRESPONDENCE David G Harrison: dharr02{at}emory.edu
Hypertension promotes atherosclerosis and is a major source of morbidity and mortality. We show that mice lacking T and B cells (RAG-1–/– mice) have blunted hypertension and do not develop abnormalities of vascular function during angiotensin II infusion or desoxycorticosterone acetate (DOCA)–salt. Adoptive transfer of T, but not B, cells restored these abnormalities. Angiotensin II is known to stimulate reactive oxygen species production via the nicotinamide adenosine dinucleotide phosphate (NADPH) oxidase in several cells, including some immune cells. Accordingly, adoptive transfer of T cells lacking the angiotensin type I receptor or a functional NADPH oxidase resulted in blunted angiotensin II–dependent hypertension and decreased aortic superoxide production. Angiotensin II increased T cell markers of activation and tissue homing in wild-type, but not NADPH oxidase–deficient, mice. Angiotensin II markedly increased T cells in the perivascular adipose tissue (periadventitial fat) and, to a lesser extent the adventitia. These cells expressed high levels of CC chemokine receptor 5 and were commonly double negative (CD3+CD4–CD8–). This infiltration was associated with an increase in intercellular adhesion molecule-1 and RANTES in the aorta. Hypertension also increased T lymphocyte production of tumor necrosis factor (TNF)
, and treatment with the TNF
antagonist etanercept prevented the hypertension and increase in vascular superoxide caused by angiotensin II. These studies identify a previously undefined role for T cells in the genesis of hypertension and support a role of inflammation in the basis of this prevalent disease. T cells might represent a novel therapeutic target for the treatment of high blood pressure.
Abbreviations used: CCR, CC chemokine receptor; DN, double-negative; DOCA, desoxycorticosterone acetate; ICAM, intercellular adhesion molecule; NADPH, nicotinamide adenosine dinucleotide phosphate; NO, nitric oxide; RAG, recombinase-activating gene; ROS, reactive oxygen species.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Facebook
Reddit
Technorati
Twitter What's this?
Related Article
-
T cells raise the tension
- Hema Bashyam
J. Exp. Med. 2007 204: 2243.
[Full Text]
[PDF]
This article has been cited by other articles:
-
Wenzel, P., Schulz, E., Munzel, T.
(2009). Protein Kinase C-Inhibiting Properties of the Losartan Metabolite EXP3179 Make the Difference. Hypertension
54: 707-709
[Full Text]
-
Stegbauer, J., Lee, D.-H., Seubert, S., Ellrichmann, G., Manzel, A., Kvakan, H., Muller, D. N., Gaupp, S., Rump, L. C., Gold, R., Linker, R. A.
(2009). Role of the renin-angiotensin system in autoimmune inflammation of the central nervous system. Proc. Natl. Acad. Sci. USA
106: 14942-14947
[Abstract]
[Full Text]
-
Platten, M., Youssef, S., Hur, E. M., Ho, P. P., Han, M. H., Lanz, T. V., Phillips, L. K., Goldstein, M. J., Bhat, R., Raine, C. S., Sobel, R. A., Steinman, L.
(2009). Blocking angiotensin-converting enzyme induces potent regulatory T cells and modulates TH1- and TH17-mediated autoimmunity. Proc. Natl. Acad. Sci. USA
106: 14948-14953
[Abstract]
[Full Text]
-
Verlohren, S., Muller, D. N., Luft, F. C., Dechend, R.
(2009). Immunology in Hypertension, Preeclampsia, and Target-Organ Damage. Hypertension
54: 439-443
[Full Text]
-
Xu, J., Wang, S., Wu, Y., Song, P., Zou, M.-H.
(2009). Tyrosine Nitration of PA700 Activates the 26S Proteasome to Induce Endothelial Dysfunction in Mice With Angiotensin II-Induced Hypertension. Hypertension
54: 625-632
[Abstract]
[Full Text]
-
Didion, S. P., Kinzenbaw, D. A., Schrader, L. I., Chu, Y., Faraci, F. M.
(2009). Endogenous Interleukin-10 Inhibits Angiotensin II-Induced Vascular Dysfunction. Hypertension
54: 619-624
[Abstract]
[Full Text]
-
Rickard, A. J., Morgan, J., Tesch, G., Funder, J. W., Fuller, P. J., Young, M. J.
(2009). Deletion of Mineralocorticoid Receptors From Macrophages Protects Against Deoxycorticosterone/Salt-Induced Cardiac Fibrosis and Increased Blood Pressure. Hypertension
54: 537-543
[Abstract]
[Full Text]
-
Kvakan, H., Kleinewietfeld, M., Qadri, F., Park, J.-K., Fischer, R., Schwarz, I., Rahn, H.-P., Plehm, R., Wellner, M., Elitok, S., Gratze, P., Dechend, R., Luft, F. C., Muller, D. N.
(2009). Regulatory T Cells Ameliorate Angiotensin II-Induced Cardiac Damage. Circulation
119: 2904-2912
[Abstract]
[Full Text]
-
Yang, Z., Sharma, A. K., Marshall, M., Kron, I. L., Laubach, V. E.
(2009). NADPH Oxidase in Bone Marrow-Derived Cells Mediates Pulmonary Ischemia-Reperfusion Injury. Am. J. Respir. Cell Mol. Bio.
40: 375-381
[Abstract]
[Full Text]
-
Robinson, S. T., Taylor, W. R.
(2009). Beyond the Adventitia: Exploring the Outer Limits of the Blood Vessel Wall. Circ. Res.
104: 416-418
[Full Text]
-
Hoch, N. E., Guzik, T. J., Chen, W., Deans, T., Maalouf, S. A., Gratze, P., Weyand, C., Harrison, D. G.
(2009). Regulation of T-cell function by endogenously produced angiotensin II. Am. J. Physiol. Regul. Integr. Comp. Physiol.
296: R208-R216
[Abstract]
[Full Text]
-
Abe, J.-i., Woo, C.-H.
(2009). NADPH Oxidase in Vascular Injury: A New Insight About Its Regulation and Role in T Cells. Circ. Res.
104: 147-149
[Full Text]
-
Mann, J. F. E.
(2009). What's new in hypertension 2008?. Nephrol Dial Transplant
24: 38-42
[Full Text]
-
Luft, F. C
(2008). Renin-angiotensin system-related highlights from the High Blood Pressure Research Conference annual meeting. Journal of Renin-Angiotensin-Aldosterone System
9: 242-247
[Abstract]
-
Zhang, W.-Y., Schwartz, E. A., Permana, P. A., Reaven, P. D.
(2008). Pioglitazone Inhibits the Expression of Inflammatory Cytokines From Both Monocytes and Lymphocytes in Patients With Impaired Glucose Tolerance. Arterioscler. Thromb. Vasc. Bio.
28: 2312-2318
[Abstract]
[Full Text]
-
Shahid, M., Francis, J., Majid, D. S. A.
(2008). Tumor necrosis factor-{alpha} induces renal vasoconstriction as well as natriuresis in mice. Am. J. Physiol. Renal Physiol.
295: F1836-F1844
[Abstract]
[Full Text]
-
Feig, D. I., Kang, D.-H., Johnson, R. J.
(2008). Uric Acid and Cardiovascular Risk. NEJM
359: 1811-1821
[Full Text]
-
Crowley, S. D., Frey, C. W., Gould, S. K., Griffiths, R., Ruiz, P., Burchette, J. L., Howell, D. N., Makhanova, N., Yan, M., Kim, H.-S., Tharaux, P.-L., Coffman, T. M.
(2008). Stimulation of lymphocyte responses by angiotensin II promotes kidney injury in hypertension. Am. J. Physiol. Renal Physiol.
295: F515-F524
[Abstract]
[Full Text]
-
Schiffrin, E. L.
(2008). The Flame That Lights the Fire: Oxidative Stress, Inflammation, and Renal Damage in Angiotensin II-Induced Hypertension. Hypertension
52: 205-206
[Full Text]
-
Bouloumie, A., Casteilla, L., Lafontan, M.
(2008). Adipose Tissue Lymphocytes and Macrophages in Obesity and Insulin Resistance: Makers or Markers, and Which Comes First?. Arterioscler. Thromb. Vasc. Bio.
28: 1211-1213
[Full Text]
-
Miyazaki, R., Ichiki, T., Hashimoto, T., Inanaga, K., Imayama, I., Sadoshima, J., Sunagawa, K.
(2008). SIRT1, a Longevity Gene, Downregulates Angiotensin II Type 1 Receptor Expression in Vascular Smooth Muscle Cells. Arterioscler. Thromb. Vasc. Bio.
28: 1263-1269
[Abstract]
[Full Text]
-
Wolfort, R. M., Stokes, K. Y., Granger, D. N.
(2008). CD4+ T lymphocytes mediate hypercholesterolemia-induced endothelial dysfunction via a NAD(P)H oxidase-dependent mechanism. Am. J. Physiol. Heart Circ. Physiol.
294: H2619-H2626
[Abstract]
[Full Text]
-
Gratze, P., Dechend, R., Stocker, C., Park, J.-K., Feldt, S., Shagdarsuren, E., Wellner, M., Gueler, F., Rong, S., Gross, V., Obst, M., Plehm, R., Alenina, N., Zenclussen, A., Titze, J., Small, K., Yokota, Y., Zenke, M., Luft, F. C., Muller, D. N.
(2008). Novel Role for Inhibitor of Differentiation 2 in the Genesis of Angiotensin II-Induced Hypertension. Circulation
117: 2645-2656
[Abstract]
[Full Text]
-
Sriramula, S., Haque, M., Majid, D. S.A., Francis, J.
(2008). Involvement of Tumor Necrosis Factor-{alpha} in Angiotensin II-Mediated Effects on Salt Appetite, Hypertension, and Cardiac Hypertrophy. Hypertension
51: 1345-1351
[Abstract]
[Full Text]
-
Helmut, G.
(2008). T-cells in angiotensin-II-induced vascular damage. Nephrol Dial Transplant
23: 1107-1108
[Full Text]
-
Shimokawa, H.
(2008). Bone Marrow-Derived Matrix Metalloproteinase-14: A Novel Target for Plaque Stability. Circulation
117: 863-865
[Full Text]
-
Satoh, K., Berk, B. C.
(2008). Circulating smooth muscle progenitor cells: novel players in plaque stability. Cardiovasc Res
77: 445-447
[Full Text]
-
Brown, N. J.
(2008). Aldosterone and Vascular Inflammation. Hypertension
51: 161-167
[Full Text]